Table of Contents
Akums Drugs And Pharmaceuticals IPO
The IPO season is on and today we will discuss about the IPO of Akums Drugs & Pharmaceuticals Limited. The allotment of this IPO will be done by August 1, and its total size is Rs 18,560 crore, of which the fresh issue is Rs 680 crore.
Details about the company:
One of the top pharmaceutical contract development and manufacturing organizations (CDMOs) is Akums Drugs & Pharmaceuticals Limited. The company serves both the Indian and global markets with pharmaceutical goods and services. There are almost 4,000 different formulas and over 60 different doses available. In addition, the business produces APIs, or active pharmaceutical ingredients.
Akums Drugs & Pharmaceuticals IPO – Key Dates
| Event | Date |
|---|---|
| IPO Open Date | Tuesday, July 30, 2024 |
| IPO Close Date | Thursday, August 1, 2024 |
| Basis of Allotment | Friday, August 2, 2024 |
| Initiation of Refunds | Monday, August 5, 2024 |
Akums Drugs Financial
Although the company’s revenue is growing at a rate of about 13%, profitability varies. The business lost money in 2022, but in 2023 it managed to turn a profit. That being said, the company’s profitability is now stable. The company has approximately Rs 700 crore in net value and approximately Rs 491 crore in debt.
Company position and competition:
Competitors of Akums Drugs include Divi’s Laboratories, Sven Pharma, Gland Pharma, Torrent Pharma, Alkam Laboratories, Aries Life Science, JB Chemical, and Mankind Pharma. Comparing with these companies, Akums Drugs IPO can be an important opportunity.
Open Free Demat Account Online In 5 Minutes
IPO details:
The total size of the IPO is Rs 18,560 crore, out of which Rs 680 crore is a fresh issue and the rest is an offer for sale. Retail investors have been given a 10% stake in the IPO, which was earlier 35%.
Premium and Investment Tips:
About a quarter of the IPO price of Akums Drugs & Pharmaceuticals is the gray market premium. It’s crucial to consider the company’s finances and the state of the market before making an investment in this IPO.
Allotment and Investment:
The IPO subscription will run from July 30 to August 1. 12,292 people are expected to get allotment in the retail category, while 4,403 people in the HNI category and 8,807 people in the Big HNI category may get allotment.
Conclusion:
One or two lots are options if you’re thinking about investing in the Akums Drugs & Pharmaceuticals IPO. This might be an excellent opportunity given the company’s size and future potential.
Follow us to learn about market trends, fresh initial public offerings, and other crucial information. I’m grateful.
